Parent, Cassandra http://orcid.org/0000-0002-0825-0480
Mauvieux, Benoît http://orcid.org/0000-0003-4862-6531
Lespagnol, Elodie http://orcid.org/0000-0002-1076-822X
Hingrand, Corentin http://orcid.org/0000-0003-3914-2738
Vauthier, Jean-Charles http://orcid.org/0000-0003-3796-6370
Noirez, Philippe http://orcid.org/0000-0003-4538-803X
Hurdiel, Rémy http://orcid.org/0000-0002-4711-0077
Martinet, Quentin
Delaunay, Pierre-Louis http://orcid.org/0000-0002-7421-8219
Besnard, Stéphane http://orcid.org/0000-0002-9659-8005
Heyman, Joris http://orcid.org/0000-0002-0327-7924
Gabel, Virginie http://orcid.org/0000-0002-9792-1468
Baron, Pauline
Gamelin, François-Xavier http://orcid.org/0000-0002-0188-7219
Maboudou, Patrice http://orcid.org/0000-0002-3578-7830
Rabasa-Lhoret, Rémi http://orcid.org/0000-0003-4706-5170
Jouffroy, Romain http://orcid.org/0000-0003-2616-6132
Heyman, Elsa http://orcid.org/0000-0002-9340-7592
Clinical trials referenced in this document:
Documents that mention this clinical trial
Glycaemic Effects of a 156-km Ultra-trail Race in Athletes: An Observational Field Study
https://doi.org/10.1007/s40279-024-02013-4
Funding for this research was provided by:
RIN TREMPLIN APEEX
International Joint Laboratory REGALE-1
Type 1 Running Team Association
Institut Universitaire de France
Hauts-de-France Regional Authority
Article History
Accepted: 25 February 2024
First Online: 30 March 2024
Declarations
:
: This protocol was partly financed by the RIN TREMPLIN APEEX (Adaptation <i>Physiologiques En Environnements Extrêmes</i> – 2020/2022) supported by the Normandy Region – France and the European Regional Development Fund (ERDF). This study was undertaken as part of the project run by the International Joint Laboratory REGALE-1 (Glycemic Regulation During Exercise in Type 1 Diabetes), bringing together the URePSSS (Lille University) and IRCM (Montréal) and involving an international ‘SPORT-1’ Chair for R. Rabasa-Lhoret (I-SITE ULNE, WILL grant). This study was supported in part by grants from the Type 1 Running Team Association. EH received a grant from the <i>Institut Universitaire de France</i>, and CP received grant assistance as a doctoral student from the Hauts-de-France Regional Authority.
: The authors declare no competing interests.
: Approval institution, Ouest III Ethics Committee; ethics number, 2021-A01765-36; date of approval, 26 October 2021. Trial registration number, NCT05538442 2022-09-21, retrospectively registered. The study was performed in accordance with the ethical standards in the Declaration of Helsinki.
: All participants were fully informed of the nature and possible risks of the experimental procedures before their written informed consent was obtained.
: Not applicable.
: Not applicable.
: All authors read and approved the final version. EH and BM designed the experiments. FXG and RRL gave advice on some methodological points. CP, EL, EH, JCV, RH, PLD, SB, PN, VG, PB, QM, and RJ carried out the experiments and collected the data. PM performed blood analyses. EH and CP analysed the data. JH created algorithms for analyses of glycaemic excursions and variability. BM and CH recruited the participants, organized the protocol and the race, and submitted the protocol to the ethics committee. EH and CP wrote the manuscript. All authors were involved in reviewing the manuscript. EH has guaranteed the integrity of the study throughout its duration and, as such, had full access to data and takes responsibility for the integrity of the data and accuracy of the data analysis.
: All data related to this article are available on ExternalRef removed platform (ExternalRef removed).